Request access

LSD is open to a first group of founders, investors and business-development teams. Tell us who you are and what you follow, and we will come back to you by email.

Full nameWork emailOrganisation

You are

Founder or executive of a biotechInvestor (VC, family office, fund, business angel)Business development or licensing at a pharma or biotechAdviser, consultant or bankerOther

What would you use LSD for? (optional)

Competitive and strategic watchKey drivers of an asset's valueFaster due diligenceFinding companies and assets (deal flow)Monitoring a portfolioFinding partners or licenseesPreparing a fundraisingBenchmarking clinical trialsPatent landscape

Companies, targets or diseases you follow (optional)Anything else (optional)

Website

I have read how Ayca handles this request in the privacy notice. My details are used only to answer it.

What happens next

An Ayca analyst reads your request.
You receive an email to set your password and a sign-in code app.
The companies you named can be added to the nightly updates if they are not tracked yet.

LSD · A standalone platform by Ayca · Sources: ClinicalTrials.gov and PubMed (U.S. National Library of Medicine; processed nightly, fields normalised by LSD) · Source: EMA, Clinical Trials Information System · European Patent Office (Open Patent Services) · company websites and press releases (facts and short excerpts, each linked to its page). Unvalidated items are shown and flagged. People listed in LSD: privacy notice.